πŸ‡ΊπŸ‡Έ FDA
Patent

US 7105695

Synthesis of combretastatin A-2 prodrugs

granted A61PA61P35/00A61P43/00

Quick answer

US patent 7105695 (Synthesis of combretastatin A-2 prodrugs) held by ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00, A61P43/00, A61P9/00